Lexeo Therapeutics shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Lexeo Therapeutics (LXEO) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Lexeo Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Lexeo Therapeutics held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Lexeo Therapeutics by MetLife Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $355k | 36k | 9.93 |
| 2024-12-31 | $94k | 14k | 6.58 |
| 2024-09-30 | $129k | 14k | 9.04 |
| 2024-06-30 | $103k | 6.4k | 16.04 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors